DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.
Alesi Surgical
Venture Round in 2024
Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.
Enterprise Therapeutics
Series B in 2024
Enterprise Therapeutics is a United Kingdom-based drug discovery company founded in 2014 and based in Brighton. It develops novel disease-modifying therapies for respiratory diseases, including cystic fibrosis, asthma, and COPD, with a focus on addressing the underlying mechanisms of mucus congestion to improve breathing, reduce lung infections, and enhance patient quality of life.
AccelerComm
Series B in 2023
AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.
Deep Render
Series A in 2023
Deep Render is a London-based AI startup spun out from Imperial College London's Department of Computing. It develops AI-powered video and image compression technology that leverages deep learning, density estimation, unsupervised learning, and quantum techniques to improve compression efficiency. The company has proprietary, patented technology in media and biological image compression, with state-of-the-art results delivering at least a 50% efficiency gain over previous standards.
AudioScenic
Series A in 2023
AudioScenic specializes in developing advanced 3D audio technology using small speaker arrays and head tracking. This enables immersive, personalized sound experiences without the need for headphones or multiple speakers, benefiting industries such as gaming, cinema, VR, and automotive.
DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.
Kale United
Equity Crowdfunding in 2022
Kale United AB, founded in 2018 and headquartered in Stockholm, Sweden, specializes in providing advisory services to plant-based member companies. These services encompass marketing, public relations, sales and distribution, financing, community engagement, accounting, and human resources. The company focuses on supporting vegan startups and aims to foster growth within the plant-based food sector across the Nordic region.
Nexeon is an international developer and manufacturer of silicon-based anode materials for rechargeable lithium-ion batteries. The company focuses on silicon anodes to increase energy density, enabling lighter, smaller, and more cost-efficient batteries for a range of applications including electric vehicles and consumer electronics, as well as other sectors that require high-performance energy storage. Headquarters are in Oxfordshire, United Kingdom, and the company maintains operations in Japan, with a history dating back to 2006. By replacing traditional graphite anodes, Nexeon's materials aim to enhance battery performance while reducing overall carbon footprint.
Oxford Science Enterprises
Venture Round in 2022
Established in 2015, Oxford Science Enterprises partners with the University of Oxford to build science-based businesses addressing global challenges. It focuses on investments in life science, AI/software, healthcare, and deep tech sectors, aiming to create companies that tackle issues such as nuclear fusion, quantum computing, and infectious disease treatments.
Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.
MoA Technology
Series B in 2022
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.
SLAMcore Limited
Series A in 2022
SLAMcore develops simultaneous localization and mapping (SLAM) solutions for augmented/virtual reality, robotics, and autonomous vehicles. Its technology enables moving robots to localize, navigate, and understand unfamiliar surroundings using visual SLAM, sensor fusion, and event camera SLAM. The company's ETAM 2D and ETAM 3D methods demonstrate real-time, high dynamic range, and resolution intensity for event-based cameras. SLAMcore licenses its algorithms for smart technology like drones and self-driving vehicles.
GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.
First Light Fusion
Series C in 2022
First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.
Bramble Energy
Series B in 2022
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.
DiffBlue
Seed Round in 2022
DiffBlue is a software company that develops AI-powered automated testing and code automation tools. It automates coding tasks such as generating unit tests, bug fixing, refactoring, translating code between languages, and producing original code to meet specifications. Its automated testing software for Java creates fully autonomous unit tests, maintains regression tests, and provides insights into test coverage, code testability, complexity and dependencies. The technology uses reinforcement learning to write tests that compile, run, and detect bugs, reducing manual testing effort and accelerating software development. In addition to test generation, DiffBlue offers security testing capabilities to identify and fix exploits. DiffBlue originated as a spin-out of the University of Oxford's AI research group and is based in Oxford, United Kingdom.
Navenio
Venture Round in 2021
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.
Ieso Digital Health
Series B in 2021
Ieso Digital Health provides online, evidence-based mental health therapy via a digital platform, enabling one-to-one cognitive behavioral therapy delivered by accredited therapists in a virtual, convenient setting. The service covers common mental health conditions such as anxiety, depression, OCD, PTSD, sleep problems, and related issues, and also supports patients with chronic physical health problems, medically unexplained symptoms, and other cognitive concerns. The company uses proprietary technology, including natural language processing and artificial intelligence, to monitor therapist protocol adherence and risk in real time, enabling text-based therapy sessions. It serves health providers including the NHS, private individuals, and employers, expanding access to clinically validated care outside traditional in-person settings.
Ieso Digital Health
Series B in 2021
Ieso Digital Health provides online, evidence-based mental health therapy via a digital platform, enabling one-to-one cognitive behavioral therapy delivered by accredited therapists in a virtual, convenient setting. The service covers common mental health conditions such as anxiety, depression, OCD, PTSD, sleep problems, and related issues, and also supports patients with chronic physical health problems, medically unexplained symptoms, and other cognitive concerns. The company uses proprietary technology, including natural language processing and artificial intelligence, to monitor therapist protocol adherence and risk in real time, enabling text-based therapy sessions. It serves health providers including the NHS, private individuals, and employers, expanding access to clinically validated care outside traditional in-person settings.
Ultraleap
Series D in 2021
Ultraleap specializes in developing and commercializing innovative haptic control systems. Founded in 2013, the company is renowned for its mid-air haptics and 3D hand tracking technologies. Ultraleap's solutions include Leap Motion Controller for optical hand tracking, VR Developer Mount for virtual reality experiences, and Gemini, a hand tracking platform. Its applications span across extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment.
Hinge Health
Series E in 2021
Hinge Health is a digital health company that designs and delivers technology-enabled musculoskeletal care for employees and self-insured employers. The platform combines wearable sensors, computer vision and a clinical team to provide digital physical therapy, guidance on behavior change, and access to orthopedic expertise via a single app. It targets back, neck, shoulder and joint pain and aims to improve access to high-quality care while reducing costs for clients. The solution supports self-management with remote monitoring and personalized programs, enabling physical therapists, health coaches and surgeons to coordinate care. Founded in 2015 and headquartered in San Francisco, it serves businesses and individuals seeking scalable MSK treatment and prevention.
Monolith AI
Series A in 2021
Monolith AI Limited is a software company based in London, United Kingdom, founded in 2016. The company specializes in developing algorithms that integrate engineering simulations with machine learning techniques to enhance the engineering design process. By leveraging existing simulation and test data, Monolith AI enables engineers to predict the behavior of new products more accurately, thereby optimizing research and development efforts. This approach reduces the need for extensive simulations, tests, and prototypes, allowing companies to accelerate product development and improve overall product quality. Monolith AI was previously known as UQuant Limited until it rebranded in June 2018.
Alesi Surgical
Venture Round in 2021
Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.
Oxford Nanopore Technologies
Venture Round in 2021
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.
Oxular
Venture Round in 2021
Oxular is a clinical-stage company developing innovative retinal therapeutics. It focuses on transforming the treatment of retinal diseases by offering tissue-specific drug delivery solutions to address unmet patient needs, such as age-related macular degeneration and diabetic macular edema.
C-Capture Limited
Venture Round in 2021
C-Capture Limited designs and develops solvent systems that capture carbon dioxide from flue gases and other emission sources. The company’s proprietary technology enables reversible, non‑toxic removal of CO2 in post‑combustion capture processes, making power generation and hard‑to‑abate industries more environmentally friendly and cost‑effective. Founded in 2008, the firm is headquartered in Leeds, United Kingdom.
Econic Technologies
Debt Financing in 2020
Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.
AudioScenic
Series A in 2020
AudioScenic specializes in developing advanced 3D audio technology using small speaker arrays and head tracking. This enables immersive, personalized sound experiences without the need for headphones or multiple speakers, benefiting industries such as gaming, cinema, VR, and automotive.
AccelerComm
Series A in 2020
AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.
Bramble Energy
Series A in 2020
Founded in London in 2016, Bramble Energy specializes in designing and manufacturing high-performance, low-cost fuel cell stacks using printed circuit board (PCB) technology. Their products cater to stationary, portable, and automotive sectors, with customizable options available.
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.
IBEX Innovations
Venture Round in 2020
IBEX Innovations develops innovative X-ray detector technology that generates high sensitivity materials information from standard detectors. Its core product, IBEX multi absorption plate (MAP) technology, integrates detectors to provide material insights while maintaining speed and resolution characteristics of underlying sensors. Applications include bone mineral density measurement, electronics inspection, food safety, and security screening.
Mixergy Ltd, founded in 2014 and headquartered in Cassington, United Kingdom, specializes in the development of innovative energy storage solutions, particularly hot water tanks. The company's technology is designed to enhance energy efficiency and support the integration of renewable energy sources, such as solar power and heat pumps. By providing a cost-effective means to store and utilize energy, Mixergy aims to facilitate grid balancing and optimize the use of renewable power, contributing to a more sustainable energy landscape.
WaveOptics
Series C in 2019
WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and headquartered in Abingdon-on-Thames, United Kingdom, the company focuses on providing key optical components for augmented reality applications. WaveOptics employs patented technology that utilizes waveguide holography and photonic crystals to create lightweight, high-performance displays. Their innovative designs feature a high field of view and full RGB color, allowing for an enriched user experience without the bulk typically associated with traditional augmented reality systems. The company has established strategic partnerships with leading firms such as Compal, Wistron, and Plessey to enhance its product offerings and market reach.
Azuri Technologies
Corporate Round in 2019
Azuri Technologies develops, manufactures, and installs solar power products for off-grid emerging markets in Africa and the UK. Its key offerings include AzuriTV (solar-powered television), Indigo (pay-as-you-go solar electricity system using scratch cards), Azuri Quad (solar home system with LED lights, radio/torch, mobile charging), and PayGo (solar home system for rural households). Founded in 2012, the company is headquartered in Cambridge, UK, with distribution networks across multiple African countries.
IBEX Innovations
Venture Round in 2019
IBEX Innovations develops innovative X-ray detector technology that generates high sensitivity materials information from standard detectors. Its core product, IBEX multi absorption plate (MAP) technology, integrates detectors to provide material insights while maintaining speed and resolution characteristics of underlying sensors. Applications include bone mineral density measurement, electronics inspection, food safety, and security screening.
Founded in 2012, Aqdot specializes in innovative microencapsulation technology. Its patented one-step shrink-wrap approach combines emulsion technology and supramolecular chemistry to create smart microcapsules with customizable properties. This energy-efficient manufacturing process serves various industries, including household care, agrochemicals, and food sectors.
Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, that specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment. Founded in 2014, Inivata has developed TAm-Seq technology, which enables the detection and analysis of genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples. This innovative approach, known as liquid biopsy, provides a significant advancement over traditional invasive biopsies by allowing for easier detection, monitoring, and treatment of cancer. Inivata's platform aims to assist oncologists in making informed treatment decisions by improving the understanding of cancer dynamics, including monitoring treatment responses and detecting relapses. The company has established a strategic collaboration with NeoGenomics, Inc. to further its mission in the field of cancer genomics.
AccelerComm
Seed Round in 2019
AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.
C-Capture Limited
Venture Round in 2019
C-Capture Limited designs and develops solvent systems that capture carbon dioxide from flue gases and other emission sources. The company’s proprietary technology enables reversible, non‑toxic removal of CO2 in post‑combustion capture processes, making power generation and hard‑to‑abate industries more environmentally friendly and cost‑effective. Founded in 2008, the firm is headquartered in Leeds, United Kingdom.
AudioScenic
Seed Round in 2019
AudioScenic specializes in developing advanced 3D audio technology using small speaker arrays and head tracking. This enables immersive, personalized sound experiences without the need for headphones or multiple speakers, benefiting industries such as gaming, cinema, VR, and automotive.
WaveOptics
Series C in 2018
WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and headquartered in Abingdon-on-Thames, United Kingdom, the company focuses on providing key optical components for augmented reality applications. WaveOptics employs patented technology that utilizes waveguide holography and photonic crystals to create lightweight, high-performance displays. Their innovative designs feature a high field of view and full RGB color, allowing for an enriched user experience without the bulk typically associated with traditional augmented reality systems. The company has established strategic partnerships with leading firms such as Compal, Wistron, and Plessey to enhance its product offerings and market reach.
Ultraleap
Series C in 2018
Ultraleap specializes in developing and commercializing innovative haptic control systems. Founded in 2013, the company is renowned for its mid-air haptics and 3D hand tracking technologies. Ultraleap's solutions include Leap Motion Controller for optical hand tracking, VR Developer Mount for virtual reality experiences, and Gemini, a hand tracking platform. Its applications span across extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment.
IBEX Innovations
Venture Round in 2018
IBEX Innovations develops innovative X-ray detector technology that generates high sensitivity materials information from standard detectors. Its core product, IBEX multi absorption plate (MAP) technology, integrates detectors to provide material insights while maintaining speed and resolution characteristics of underlying sensors. Applications include bone mineral density measurement, electronics inspection, food safety, and security screening.
Yoyo Wallet
Series C in 2018
Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.
Garrison Technology Limited, established in London, UK, in 2014, specializes in enterprise cybersecurity solutions. The company focuses on developing innovative anti-malware technology designed to efficiently mitigate high-impact internet-borne targeted attacks, a significant threat to modern organizations. Garrison's unique approach enables secure internet connectivity, enhances user experience, and ensures scalability for enterprises.
Dukosi
Venture Round in 2018
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.
Artios Pharma
Series B in 2018
Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2016, the company is dedicated to creating first-in-class therapies that selectively kill cancer cells by exploiting their reliance on DDR mechanisms. Artios’ product pipeline includes a range of promising candidates, such as a therapy that targets DNA polymerase theta, a protein involved in DNA repair processes, and another program focusing on a novel DDR target. The company collaborates with prominent research organizations, including Cancer Research Technology, to enhance its development efforts and leverage expertise in DNA repair. Artios is led by a skilled team with extensive experience in drug discovery, positioning it to advance its next-generation DDR programs and contribute significantly to the field of cancer treatment.
Spirea
Pre Seed Round in 2018
Spirea Ltd is a healthcare technology company based in Harrogate, United Kingdom, focused on developing innovative antibody drug conjugates (ADCs) for cancer treatment. Established in 2015, Spirea has created a smart polymer platform that enhances the controlled delivery of drug combinations, aiming to maximize the clinical efficacy of therapies. The company's flexible approach to ADC design allows for a greater amount of drug payload to be precisely targeted at tumor cells, increasing therapeutic effects while significantly minimizing adverse side effects. This advancement enables healthcare providers to offer well-tolerated treatment options for a variety of cancer types, ultimately improving patient outcomes.
Enterprise Therapeutics
Series B in 2018
Enterprise Therapeutics is a United Kingdom-based drug discovery company founded in 2014 and based in Brighton. It develops novel disease-modifying therapies for respiratory diseases, including cystic fibrosis, asthma, and COPD, with a focus on addressing the underlying mechanisms of mucus congestion to improve breathing, reduce lung infections, and enhance patient quality of life.
Econic Technologies
Venture Round in 2018
Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.
Spirea
Pre Seed Round in 2017
Spirea Ltd is a healthcare technology company based in Harrogate, United Kingdom, focused on developing innovative antibody drug conjugates (ADCs) for cancer treatment. Established in 2015, Spirea has created a smart polymer platform that enhances the controlled delivery of drug combinations, aiming to maximize the clinical efficacy of therapies. The company's flexible approach to ADC design allows for a greater amount of drug payload to be precisely targeted at tumor cells, increasing therapeutic effects while significantly minimizing adverse side effects. This advancement enables healthcare providers to offer well-tolerated treatment options for a variety of cancer types, ultimately improving patient outcomes.
Oxehealth
Venture Round in 2017
Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring. Founded in 2012, it has developed the Oxecam software, which allows for the remote measurement of heart rate, respiratory rate, and blood oxygenation using digital video cameras. This innovative approach is particularly beneficial in medical settings, where it can enhance care for elderly and vulnerable individuals in environments where staff presence is limited. The system generates alerts for risky activities and provides objective data on patient vitals, enabling informed care planning. Oxehealth's technology combines proprietary algorithms that leverage deep learning, computer vision, and signal processing, making it suitable for various sectors, including healthcare, security, and retail. Its Digital Care Assistant supports clinicians and caregivers in mental health facilities, prisons, and home care, facilitating proactive interventions based on real-time data. Oxehealth is recognized for achieving the world’s first medical device certification for its software, demonstrating its commitment to enhancing patient care through innovative technology.
Navenio
Seed Round in 2017
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.
Kudo
Venture Round in 2017
Kudo Insurance is a developer of a mobile application designed to assess driving behavior and provide personalized car insurance solutions. The app evaluates users' driving habits through telematics, assigning an individual score that influences their insurance quotes. Users are incentivized for safe driving with Kudo Koins, a form of in-app currency that can be exchanged for goods or entries into cash prize draws. This gamified approach not only enhances user engagement but also encourages referrals and sustained app usage. The driving data collected may serve as evidence in the event of an accident, adding an extra layer of utility for users. With its innovative data science and risk selection techniques, Kudo aims to establish itself as a leading motor insurer, starting in the UK and planning to expand internationally within the next few years.
Touchstone Innovations
Acquisition in 2017
Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over ÂŁ1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.
Inductosense
Series A in 2017
Inductosense Ltd is a manufacturer based in Bristol, United Kingdom, specializing in wireless and battery-free sensors designed for the detection of cracks, corrosion, and defects in various structures and products. Founded in 2015, the company offers innovative solutions such as the WAND Evaluation System, which includes a set of sensors, a handheld measurement probe, and a sensor fixing kit for measuring structural thickness. Additionally, Inductosense develops TRND systems for monitoring internal corrosion and erosion in pipework and vessels. The sensors can be permanently affixed to surfaces and are capable of operating beneath coatings, insulation, or repairs. They utilize a passive technology that relies on non-contact inductive coupling to receive power and transmit signals, allowing for fast and repeatable inspections. Inductosense's products are applicable in the inspection of large structures, composite repairs, and remote monitoring, providing clients with reliable data for maintenance and safety assessments.
Eight19
Venture Round in 2017
Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.
Creavo Medical Technologies
Series B in 2017
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.
Alesi Surgical
Venture Round in 2017
Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.
Ultraleap
Series B in 2017
Ultraleap specializes in developing and commercializing innovative haptic control systems. Founded in 2013, the company is renowned for its mid-air haptics and 3D hand tracking technologies. Ultraleap's solutions include Leap Motion Controller for optical hand tracking, VR Developer Mount for virtual reality experiences, and Gemini, a hand tracking platform. Its applications span across extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment.
Saw DX
Venture Round in 2017
SAW DX Ltd is a technology development company based in Glasgow, United Kingdom, that specializes in designing and manufacturing point-of-care (POC) diagnostic devices. The company leverages innovative Acoustic-Flow technology, which utilizes surface acoustic waves to drive diagnostic tests by manipulating fluid movement and microstructures on disposable chips. This approach allows for on-chip sample processing without the need for preprocessing, streamlining the diagnostic process. SAW DX's product offerings include prototypes for diagnosing sexually transmitted infections, demonstrator readers and cartridges for tuberculosis assays, and platforms for enriching parasites and performing molecular detection with low-cost disposable chips. The company primarily serves life sciences and diagnostics organizations seeking to enhance their diagnostic capabilities through advanced POC solutions. Incorporated in 2013, SAW DX aims to provide faster, more efficient, and cost-effective diagnostic methods for infectious diseases.
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.
Parkwalk Advisors
Acquisition in 2016
Parkwalk Advisors is a London-based venture capital firm that focuses on UK technology companies with IP backing, primarily those spun out from UK universities. The firm invests across seed to growth stages, including late-stage rounds, and is stage-agnostic, aiming to support unlisted companies with freedom to operate. It concentrates on companies originating from university research, especially in Cambridge and across the UK, and targets sectors such as healthcare, energy, materials, technology, artificial intelligence, big data, life sciences, cleantech, medtech, quantum computing, and the apps ecosystem. Typical investments range from about ÂŁ0.3 million to ÂŁ10 million, with capital structures kept in a single share class, and the firm may provide equity or debt financings. Investments are generally planned over a three- to eight-year horizon.
Oxford Nanopore Technologies
Venture Round in 2016
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.
AccelerComm
Seed Round in 2016
AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.
Cambridge Innovation Capital
Venture Round in 2016
Cambridge Innovation Capital is a Cambridge-based venture capital firm that specializes in early-stage and growth investments in life sciences and technology. It focuses on companies affiliated with the University of Cambridge or the Cambridge Cluster and seeks to back innovations in therapeutics, medtech and diagnostics, digital health, genomics and proteomics, artificial intelligence, the Internet of Things, quantum technologies, and autonomous systems. The organization provides long-term equity capital to help portfolio companies bridge development stages and scale, with a strong emphasis on opportunities arising from the Cambridge ecosystem. Since its founding in 2013, Cambridge Innovation Capital has established itself as a leading investor within that community, leveraging close ties to academia to access high-potential deep-tech opportunities.
Mirriad Advertising
Series D in 2016
Mirriad Advertising, established in 2015 and headquartered in London, specializes in in-video advertising solutions. It uses artificial intelligence and computer vision technology to dynamically insert products and signage into existing video content, creating new advertising inventory for content producers and distributors. This approach enhances viewer engagement and limits commercial interruptions. Mirriad serves clients in the UK, US, China, and other countries, generating the majority of its revenue in the US.
Mixergy
Seed Round in 2016
Mixergy Ltd, founded in 2014 and headquartered in Cassington, United Kingdom, specializes in the development of innovative energy storage solutions, particularly hot water tanks. The company's technology is designed to enhance energy efficiency and support the integration of renewable energy sources, such as solar power and heat pumps. By providing a cost-effective means to store and utilize energy, Mixergy aims to facilitate grid balancing and optimize the use of renewable power, contributing to a more sustainable energy landscape.
Navenio
Seed Round in 2016
Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.
Ultraleap
Series A in 2015
Ultraleap specializes in developing and commercializing innovative haptic control systems. Founded in 2013, the company is renowned for its mid-air haptics and 3D hand tracking technologies. Ultraleap's solutions include Leap Motion Controller for optical hand tracking, VR Developer Mount for virtual reality experiences, and Gemini, a hand tracking platform. Its applications span across extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment.
BOXARR is a UK-based software company offering solutions for managing complex systems engineering, supply chain management, and product development. Its platform enables organizations to mitigate risks, identify opportunities, and optimize profitability by effectively handling interdependent systems.
Dukosi
Venture Round in 2015
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.
Seren Photonics
Venture Round in 2015
Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.
First Light Fusion
Venture Round in 2015
First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.
Avacta Group specializes in life science technologies and reagents for applications ranging from drug discovery to diagnostics. It operates through Analytical and Animal Health segments, offering tools and contract services for protein analysis in biopharmaceutical development and veterinary diagnostics.
Oxford Nanopore Technologies
Venture Round in 2015
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.
Anacail Limited is a technology company based in Glasgow, United Kingdom, founded in 2010. It specializes in the development of innovative ozone-based systems for the sterilization of products within sealed packaging. Anacail's technology generates ozone directly in the final product packaging, effectively oxidizing surface contaminants and eliminating microorganisms without leaving any residual chemicals. This approach not only enhances food safety and extends shelf life but also addresses handling and safety concerns typically associated with ozone use. The company provides equipment for integration into food processing lines, as well as devices for medical sterilization, offering a safe and efficient method for achieving chemical-free sterilization of packaged goods.
Relitect
Seed Round in 2015
Relitect Limited is a technology company based in Motherwell, United Kingdom, focused on developing innovative diagnostic solutions for the life sciences industry. Founded in 2014, Relitect specializes in a novel assay platform that enables label-free electrochemical detection of binding events. This proprietary technology allows for the highly sensitive analysis of proteins, small molecules, and nucleic acids, making it suitable for clinical diagnostics and research applications. By utilizing small sample volumes and a multiplexed format, Relitect's technology minimizes sample interference and eliminates the potential for cross-talk between labeled reagents, enhancing the accuracy of biomarker detection.
Dukosi
Venture Round in 2014
Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.
Eight19
Venture Round in 2014
Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.
Ultraleap
Seed Round in 2014
Ultraleap specializes in developing and commercializing innovative haptic control systems. Founded in 2013, the company is renowned for its mid-air haptics and 3D hand tracking technologies. Ultraleap's solutions include Leap Motion Controller for optical hand tracking, VR Developer Mount for virtual reality experiences, and Gemini, a hand tracking platform. Its applications span across extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment.
Intelligent Ultrasound Group
Venture Round in 2014
Intelligent Ultrasound Group is a company specializing in the development, marketing, and distribution of medical training simulators and clinical ultrasound software. Based in Cardiff, United Kingdom, it offers a range of innovative products designed to enhance the quality and reliability of medical ultrasound. Its clinical AI software products, including ScanNav Audit, ScanNav AutoCapture, and ScanNav AnatomyGuide, provide real-time support and automation in ultrasound procedures, such as fetal anomaly scans and the identification of key anatomical structures. The company's training simulators, such as ScanTrainer for obstetrics and gynecology, HeartWorks for cardiac training, and BodyWorks for emergency medicine, are widely used to educate medical professionals. Intelligent Ultrasound Group, which was founded in 2004 and formerly known as MedaPhor Group, has a significant presence in the United Kingdom, North America, and other international markets.
Perpetuum
Series C in 2014
Perpetuum Ltd. is a company based in Southampton, United Kingdom, that specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 as a technology spin-off from the University of Southampton, Perpetuum has developed innovative self-powered wireless sensor solutions designed for condition monitoring in various industries, including rail, oil and gas, chemicals, and power generation. Its flagship products convert mechanical vibration into electrical energy, allowing for the operation of autonomous, maintenance-free wireless sensor nodes that transmit critical data on equipment health and performance. Perpetuum is recognized as the global leader in vibration energy harvesting, continually advancing the practical applications of this technology to enhance operational efficiency and safety in industrial environments.
Blooie Limited is a Newcastle upon Tyne-based company that operates an intelligent conversation platform designed for online businesses to facilitate real-time interactions with their customers. Founded in 2011, Blooie's platform enables website owners to engage in informed conversations with users, enhancing customer satisfaction and driving conversion rates. The platform provides real-time analytics and a dashboard that tracks conversion metrics, allowing businesses to assess their customer engagement effectively. Users can communicate with site owners, other Blooie users, or their social media contacts without leaving the website, which helps to keep them engaged longer. By streamlining customer interactions and offering valuable insights, Blooie supports online businesses in improving their overall performance and fostering meaningful connections with their audience.
Oxford Nanopore Technologies
Venture Round in 2014
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.
Diurnal
Venture Round in 2014
Diurnal Group plc is a specialty pharmaceutical company based in Cardiff, United Kingdom, that specializes in developing hormone therapeutics for the treatment of chronic endocrine conditions. Founded in 2004, the company aims to provide innovative solutions for conditions such as congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Diurnal's notable products include Alkindi, a replacement therapy for pediatric adrenal insufficiency, and Chronocort, which has completed Phase III clinical trials for adrenal insufficiency and congenital adrenal hyperplasia. The company is also advancing its early-stage pipeline with products such as Native Oral Testosterone for hypogonadism, a siRNA therapy for adrenocorticotropin-dependent Cushing's syndrome, and a modified-release preparation of T3 hormone for hypothyroidism. Diurnal's research emphasizes circadian-based endocrinology, focusing on physiological treatment regimes to address the needs of patients with rare and chronic endocrine disorders.
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.
Seren Photonics
Venture Round in 2014
Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.
Oxehealth
Venture Round in 2014
Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring. Founded in 2012, it has developed the Oxecam software, which allows for the remote measurement of heart rate, respiratory rate, and blood oxygenation using digital video cameras. This innovative approach is particularly beneficial in medical settings, where it can enhance care for elderly and vulnerable individuals in environments where staff presence is limited. The system generates alerts for risky activities and provides objective data on patient vitals, enabling informed care planning. Oxehealth's technology combines proprietary algorithms that leverage deep learning, computer vision, and signal processing, making it suitable for various sectors, including healthcare, security, and retail. Its Digital Care Assistant supports clinicians and caregivers in mental health facilities, prisons, and home care, facilitating proactive interventions based on real-time data. Oxehealth is recognized for achieving the world’s first medical device certification for its software, demonstrating its commitment to enhancing patient care through innovative technology.
Creavo Medical Technologies
Seed Round in 2014
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.
Blooie Limited is a Newcastle upon Tyne-based company that operates an intelligent conversation platform designed for online businesses to facilitate real-time interactions with their customers. Founded in 2011, Blooie's platform enables website owners to engage in informed conversations with users, enhancing customer satisfaction and driving conversion rates. The platform provides real-time analytics and a dashboard that tracks conversion metrics, allowing businesses to assess their customer engagement effectively. Users can communicate with site owners, other Blooie users, or their social media contacts without leaving the website, which helps to keep them engaged longer. By streamlining customer interactions and offering valuable insights, Blooie supports online businesses in improving their overall performance and fostering meaningful connections with their audience.
Actual Experience
Funding Round in 2013
Actual Experience provides human experience management solutions, leveraging data-driven insights to enhance digital ecosystems for businesses. Its primary offering is a cloud analytics platform that converts measurements of digital products and services into real-time digital voice of the customer quality scores.
Exonate
Seed Round in 2013
Exonate is a biotechnology company focused on developing small molecule drugs that modulate alternative messenger RNA splicing. It specializes in ophthalmology, with a primary focus on treating diabetic retinopathy and diabetic macular oedema (DMO), as well as wet age-related macular degeneration (wAMD). The company's lead program aims to provide superior efficacy through topical agents in preclinical models of wAMD.
Verticly
Seed Round in 2013
Verticly, established in 2014 and headquartered in London, offers a SaaS platform that bridges online and offline customer data for FMCG brands, retailers, and manufacturers. It specializes in omni-channel marketing, enabling real-time, personalized engagement with consumers. The platform facilitates data exchange, channel attribution, vouchering, and targeted messaging, driving purchase decisions and enhancing customer experiences.
Oxford Nanopore Technologies
Venture Round in 2013
Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.
Ubiquigent
Seed Round in 2013
Ubiquigent Limited is a biotechnology company based in Dundee, United Kingdom, founded in 2009. It specializes in the development and supply of high-quality reagents, kits, and drug discovery assay development services, focusing on the ubiquitin and ubiquitin-like signaling systems. The company provides protein degradation-focused drug discovery services and designs novel deubiquitylase (DUB) enzyme inhibitors as potential therapeutics for addressing unmet medical needs. Ubiquigent collaborates with both academic and pharmaceutical researchers, supporting fundamental scientific discovery and the exploration of innovative drug candidates targeting DUBs. Its hybrid business model emphasizes the generation of intellectual property while maintaining an internal pipeline of drug discovery programs aimed at optimizing compounds for critical therapeutic areas.
Blooie Limited is a Newcastle upon Tyne-based company that operates an intelligent conversation platform designed for online businesses to facilitate real-time interactions with their customers. Founded in 2011, Blooie's platform enables website owners to engage in informed conversations with users, enhancing customer satisfaction and driving conversion rates. The platform provides real-time analytics and a dashboard that tracks conversion metrics, allowing businesses to assess their customer engagement effectively. Users can communicate with site owners, other Blooie users, or their social media contacts without leaving the website, which helps to keep them engaged longer. By streamlining customer interactions and offering valuable insights, Blooie supports online businesses in improving their overall performance and fostering meaningful connections with their audience.
Xeros
Venture Round in 2013
Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.